Sen. Pat Toomey continues to protect Pennsylvania’s seniors by standing strong for free market principles.
He was one of the few members of the Senate Finance Committee to vote against a disastrous Medicare reform plan. The package contains one particularly damaging provision that, if enacted, would discourage drug companies from developing state-of-the-art medicines.
Sen. Toomey deserves praise for opposing it.
The Finance Committee’s plan would restructure Medicare’s “Part D” prescription drug benefit. More than one million Pennsylvanians -- mostly seniors, but also people with disabilities -- rely on this program for affordable drug coverage. Part D is a rarity among entitlement programs.
Rather than providing coverage directly, the government allows private insurers to design and administer Part D plans Insurers compete against each other to sell their plans, which are federally subsidized, to Medicare beneficiaries. This competition has tamped down spending without sacrificing quality.
In its first decade, Part D cost almost $350 billion less than originally projected. Premiums have remained stable over the years. And more than eight in 10 Part D beneficiaries are happy with their plans.
Read more:
Pat Toomey Defends Seniors
<< Read less >>
<< Read More >>
He was one of the few members of the Senate Finance Committee to vote against a disastrous Medicare reform plan. The package contains one particularly damaging provision that, if enacted, would discourage drug companies from developing state-of-the-art medicines.
Sen. Toomey deserves praise for opposing it.
The Finance Committee’s plan would restructure Medicare’s “Part D” prescription drug benefit. More than one million Pennsylvanians -- mostly seniors, but also people with disabilities -- rely on this program for affordable drug coverage. Part D is a rarity among entitlement programs.
Rather than providing coverage directly, the government allows private insurers to design and administer Part D plans Insurers compete against each other to sell their plans, which are federally subsidized, to Medicare beneficiaries. This competition has tamped down spending without sacrificing quality.
In its first decade, Part D cost almost $350 billion less than originally projected. Premiums have remained stable over the years. And more than eight in 10 Part D beneficiaries are happy with their plans.
Read more:
Pat Toomey Defends Seniors